Multiple hypothetical pathways were discussed before by Chen et al. [65] who showed GSH depletion, caspase and MAPK activation, and upregulation of p53, Bax, Fas, and Fas-L expressions in leukemia cells after propyl gallate (PG), the MG-related gallate, treatment. The gene discussed is BAX; the disease is leukemia.